1 – 46 of 46
- show: 100
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2011
- Early seizures in intracerebral hemorrhage: incidence, associated factors, and outcome
- Early seizures in intracerebral haemorrhage: incidence, associated factors and outcome
- 2006
- Synthesis and HPLC-purification of [Br-77]TMC125-R165335 (etravirine), a new anti-HIV drug of the DAPY-NNRTI class
- Influence of deposition and spray pattern of nasal powders on insulin bioavailability
- 2005
- In vivo evaluation of [I-123]-4-iodo-N-(4-(4-(2-methoxyphenyl)piperazin-1-yl)butyl)-benzamide: a potential sigma receptor ligand for SPECT studies
- 2004
- New radioiodinated carboxylic and hydroxamic matrix metalloproteinase inhibitor tracers as potential tumor imaging agents
- Synthesis and preliminary in vivo evaluation of [18F] labelled derivatives of Org 13063 as potential PET radioligands for the 5-HT1A receptor
- 2003
- Decreased 5-HT2a receptor binding in patients with anorexia nervosa
- Prefrontal 5-HT2a receptor binding index, hopelessness and personality characteristics in attempted suicide
- Synthesis and in vivo evaluation of [123I]-pyrimidine-Org 13063 as potential SPECT radioligand for the 5-HT1A receptor
- Synthesis and radiolabelling of [I-123]-4-iodo-N-(4-(4-(2-methoxyphenyl)-piperazin-1-yl)butyl)-benzamide, a potential dopamine D-3 antagonist for SPECT studies
- Regional binding index of the radiolabeled selective 5-ht2a antagonist 123I-5-1-r91150 in the normal canine brain imaged with single photon emission computed tomography
- Synthesis and radiolabelling of [I-123]-4-iodo-N-(4-(4-(2-methoxyphenyl)-piperazin-1-yl)butyl)-benzamide, a potential dopamine D-3 antagonist for SPECT studies
- Imaging of the 5-HT2A system: age-, gender-, and Alzheimer's disease-related findings
- Synthesis and in vivo evaluation in mice and rabbits of [123I]-3-(4-iodobenzyl)-8-methoxy-1,2,3,4-tetrahydrochromeno[3,4-c]pyridin-5-one as possible agent for imaging of the dopamine D4-receptor
- 2002
- Synthesis and in vitro evaluation of N,N '-diphenyl and N-naphthyl-N '-phenylguanidines as N-methyl-D-aspartate receptor ion-channel ligands.
- Biodistribution and displacement studies of the selective 5-HT2A receptor antagonist I-123-5-I-R91150 in the normal dog.
- Synthesis and in vivo evaluation of [123I]-4-iodo-N-(4-(4-(2-methoxyphenyl)-piperazin-1-yl)butyl)-benzamide, a potential sigma receptor ligand for SPECT studies
- Synthesis of [C-11] N-(2-chloro-5-thiomethylphenyl)-N '-(3-methoxyphenyl)-N '-methylguanidine ([C-11]GMOM): a candidate PET tracer for imaging the PCP site of the NMDA ion channel.
- An infected hip prosthesis in a dog diagnosed with a Tc-99m-ciprofloxacin (infecton) scan.
- 2001
- In vivo evaluation of serotonin-2A receptors in normal canine brain: a SPECT study with a selective 5-HT2a receptor ligand labelled with 123I
- Biodistribution and dosimetry of Tc-99m-RP527, a gastrin-releasing peptide (GRP) agonist for the visualization of GRP receptor-expressing malignancies
- Non-invasive methods for absolute cerebral blood flow measurement using Tc-99m-ECD: a study in healthy volunteers
- Title: Synthesis, biodistribution and blocking studies in mice of a new 123I-labeled dopamine D3 antagonist Dierckx RA, Slegers G
- Automated stereotactic standardization of brain SPECT receptor data using single-photon transmission images
- Decreased frontal serotonin 5-HT2a receptor binding index in deliberate self-harm patients.
- Biodistribution and dosimetry of 99mTc-ciprofloxacin, a promising agent for the diagnosis of bacterial infection.
- Non-invasive methods for absolute cerebral blood flow measurement using 99m-Tc-ECD: A correlation study
- Le système serotoninergique dans le comportement suicidaire
- Is there a role for agonist gastrin-releasing peptide receptor radioligands in tumour imaging?
- Synthesis and Preliminary in vivo Evaluation of 4-[123I]iodo-N-{2-[4-(6-trifluoromethylpyridin- 2-yl)-piperazin-1-yl]ethyl}benzamide, a potential SPECT radioligand for the 5- HT1a receptor.
- 2000
- Biodistribution and dosimetry of [I-123]iodo-PK 11195: a potential agent for SPET imaging of the peripheral benzodiazepine receptor
- Synthesis and in vitro stability of 123I-labelled annexin V: a potential agent for SPECT imaging of apoptotic cells.
- Pharmacological evaluation of [C-11]conepezil as tracer for visualization of acetylcholinesterase by PET.
- Technetium-99m RP527, a GRP analogue for visualisation of GRP receptor-expressing malignancies: a feasibility study.
- 1999
- In vivo evaluation in mice and metabolism in blood of human volunteers of [I-123]iodo-PK11195: a possible single-photon emission tomography tracer for visualization of inflammation.
- Biodistribution and dosimetry of (iodine-123)-iodomethyl-N,N-diethyltamoxifen, an (anti)oestrogen receptor radioligand.
- Effect of aromatic short-chain analogues of ceramide on axonal growth in hippocampal neurons.
- High-performance liquid chromatography of (11C(1-(2-chlorophenyl)-N-methyl-N-(1-methylpropyl)-3-isoquinolinecarboxamide in mice plasma and tissue and in human plasma.
- 1998
- Biodistribution and dehalogenation studies of two radiohalogenated kynurenic acid derivatives, potent antagonists of the N-methyl-D-aspartate receptor
- 1997
- Radiolabelling optimisation of 7-bromo-5-[I-123]-iodo-4-oxo-1,4-dihydroquinoline-2-carboxylic acid: A potential tracer for NMDA SPECT studies.
- Synthesis and in vivo evaluation of 7-chloro-5-[I-123]iodo-4-oxo-1,4-dihydroquinoline-2-carboxylic acid.
- Synthesis of 7-chloro-5-123I-iodokynurenic acid:a possible tracer for in vivo imaging of N-methyl-D-aspartate receptors
- 1996
- Synthesis of [Br-77] 5,7-dibromo-4-oxo-1,4-dihydroquinoline-2-carboxylic acid, a possible SPECT tracer for NMDA receptor studies.
- 1995
- SYNTHESIS OF 7-BROMO-5-IODO-4-OXO-1,4-DIHYDROQUINOLINE-2-CARBOXYLIC ACID.
- 1993
- Synthesis of (J^BT)5, 7-dibromo-4-oxo-l,4-dihydroquinoline-2-carboxylic acid for PET studies of N-methyl-D-aspartate receptors